share_log

Tracon Pharmaceuticals | EFFECT: Others

Tracon Pharmaceuticals | EFFECT: Others

Tracon Pharmaceuticals | EFFECT:其他
美股SEC公告 ·  11/04 06:04

Moomoo AI 已提取核心訊息

Tracon Pharmaceuticals, Inc. has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on November 1, 2024. The notice, identified by Accession Number 0000950170-24-119579, pertains to the submission type POS AM. The company, with CIK number 0001394319, has its filing listed under the File Number 333-270589. This SEC filing indicates that Tracon Pharmaceuticals' registration statement or post-effective amendment has been declared effective, allowing the company to proceed with the securities offering detailed in the filing.
Tracon Pharmaceuticals, Inc. has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on November 1, 2024. The notice, identified by Accession Number 0000950170-24-119579, pertains to the submission type POS AM. The company, with CIK number 0001394319, has its filing listed under the File Number 333-270589. This SEC filing indicates that Tracon Pharmaceuticals' registration statement or post-effective amendment has been declared effective, allowing the company to proceed with the securities offering detailed in the filing.
tracon pharmaceuticals公司於2024年11月1日收到了美國證券交易委員會(SEC)的生效通知。該通知的存取編號爲0000950170-24-119579,涉及提交類型pos修訂。公司的CIK編號爲0001394319,其申報列在文件號333-270589下。這份SEC申報顯示Tracon Pharmaceuticals的註冊聲明或發帖修訂已經生效,使公司能夠繼續進行文件中詳細說明的證券發行。
tracon pharmaceuticals公司於2024年11月1日收到了美國證券交易委員會(SEC)的生效通知。該通知的存取編號爲0000950170-24-119579,涉及提交類型pos修訂。公司的CIK編號爲0001394319,其申報列在文件號333-270589下。這份SEC申報顯示Tracon Pharmaceuticals的註冊聲明或發帖修訂已經生效,使公司能夠繼續進行文件中詳細說明的證券發行。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息